Skip to Content


In the US, Pertuzumab (pertuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Categories

Antineoplastic agent


Anti-HER2 monoclonal antibody

Chemical Name

Immunoglobulin G1, anti-(human ν (receptor)) (human-mousemonoclonal 2C4 heavy chain), disulfide with human-mousemonoclonal 2C4 κ-chain, dimer (WHO )

Foreign Names

  • Pertuzumabum (Latin)
  • Pertuzumab (German)
  • Pertuzumab (French)
  • Pertuzumab (Spanish)

Generic Names

Brand Names

  • Perjeta
    Chugai Pharmaceutical, Japan; Dr. F. Hoffmann-Lja - Roche, Russian Federation; Genentech, United States; Hoffmann-La Roche, Bosnia & Herzegowina; Productos Roche, Chile; Roche, Belgium; Roche, Canada; Roche, Germany; Roche, Denmark; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Ireland; Roche, Israel; Roche, Iceland; Roche, Italy; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Poland; Roche, Romania; Roche, Sweden; Roche, Thailand; Roche Products, United Kingdom; Roche Registration, Austria


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.